Aftercare: Clinical Trials

26 trials of Aftercare, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 3 not yet recruiting, 3 unknown, 2 terminated. 14 Not applicable, 3 Phase 2, 3 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable14Completed 9, Not yet recruiting 2, Terminated 2, Unknown 1
Phase 23Completed 2, Active not recruiting 1
Phase 43Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 11Completed 1

Follow Aftercare: new trials by email Literature Review of Aftercare trials Research Report on Aftercare

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU
Nuclear imaging (PSMA PET) with intravenous injection of a radiotracer one year after treatment (focal therapy) - Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis)
Phase 4Not yet recruitingUniversity Hospital, Toulouse302027-02-012026-11-05
Surgical Timing After Preoperative Hypofractionated Radiotherapy for Localized Extremity and Trunk Soft Tissue Sarcoma
hypofractionated radiotherapy (30Gy/5 fractions) and surgical resection at 1-2 weeks after treatment, hypofractionated radiotherapy (30Gy/5 fractions) and surgical resection at 4-6 weeks after treatment - Soft Tissue Sarcoma of the Trunk and Extremities
Not applicableNot yet recruitingItalian Sarcoma Group1422027-01-302026-09-02
A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer
Best Practice, Educational Intervention, Electronic Health Record Review - Skin Carcinoma
Not applicableNot yet recruitingJonsson Comprehensive Cancer Center602026-12-012026-07-01
The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.
Follow-up visit at least two years after treatment - Non-Melanoma Skin Cancer (NMSC), Basal Cell Carcinoma of Skin
Enrolling by invitationUniversity of Aarhus29002025-12-152026-01-16
The Influencing Factors of 12 Week Efficacy of Polyethylene Glycol Losenatide in Type 2 Diabetes Patients
Polyethylene Glycol Losenatide - Type2 Diabetes Mellitus
Phase 4UnknownNanjing First Hospital, Nanjing Medical University4802022-06-012022-11-10
Technology-Assisted Systems Change for Suicide Prevention
In-person TASCS, Telehealth TASCS, Self-administered TASCS - Suicide, Suicide, Attempted
Not applicableCompletedUniversity of Massachusetts, Worcester472022-02-012024-10-31
Comparative Effectiveness of the Two Splints in Trigger Finger
Pre-treatment, Post-treatment - Trigger Finger
Not applicableCompletedHacettepe University302021-06-012023-07-12
Trigger Point Injection for Myofascial Pain Syndrome in the Low Back: A Randomized Controlled Trial
Treatment of Myofascial Pain Syndrome in the low back. This intervention will be based on outcomes of the medications listed below., Evaluation of functional ability using a patient centered functional score known as the Modified Oswestry Disability Index (MODI). The intervention will be based on outcomes of medications below., Following up with participants 60-72 hours after treatment in the Emergency Department. This intervention will be based on outcomes of the medications listed below. - Low Back Pain, Myofascial Pain Syndrome Lower Back
Phase 4RecruitingMadigan Army Medical Center1802020-12-282021-01-12
Opioid Laws and Pediatric Use
Opioid Use 90-Days Post Treatment - Burns, Knee Injuries
CompletedNationwide Children's Hospital9802020-09-102024-04-30
Mobile App Postoperative Home Monitoring After Enhanced Recovery Oncologic Surgery
RecoverWell mobile app for follow-up care - Breast Cancer, Gynecologic Cancer
Not applicableCompletedAlberta Health Services, Calgary722019-06-102021-04-21
Study to Evaluate the Safety, Tolerability, PK and PD of PB2452 in Healthy Younger, Older and Elderly Subjects
PB2452 Infusion, Placebo - Sodium Chloride, Ticagrelor Oral Tablet - Pre-Treatment - Healthy
Phase 2CompletedSFJ Pharmaceuticals, Inc.232019-04-162024-05-01
Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
Cancer Educational Materials, Follow-Up Care, Questionnaire - Malignant Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm
Not applicableTerminatedUniversity of California, San Francisco2522019-04-082021-11-16
Study to Evaluate the Safety, Tolerability, PK, and PD of PB2452 in Healthy Volunteers
PB2452 Infusion, Placebo - Sodium Chloride, Ticagrelor Oral Tablet - Pre-Treatment - Healthy
Phase 1CompletedSFJ Pharmaceuticals, Inc.642018-04-032024-11-04
Medical Spastic Patient Machine Interface MSPMI : Biomechanical and Electrophysiological Assessment of the Triceps Surae Spasticity
single assessment with the MSPMI, double assessment with the MSPMI with 7 days of interval, double assessment with the MSPMI before and after treatment - Spasticity, Muscle
Not applicableCompletedNantes University Hospital672017-10-102020-11-30
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Post-Therapy - Helicobacter Pylori Infection, Gastric Ulcer
CompletedDiaSorin Inc.132017-02-142019-02-07
Polaris Oncology Survivor Transition (POST) System
POST Intervention, POST Treatment as Usual - Cancer
Phase 2CompletedPolaris Health Directions2002016-11-302019-11-26
Long-Term Exercise Training Therapy Versus Usual Care in Patients With Schizophrenia
Exercise therapy, Follow-up care as usual - Schizophrenia
Not applicableCompletedSt. Olavs Hospital482015-12-012019-10-03
SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13, Modified Medical Research Council - Carcinoma, Non-Small-Cell-Lung, Non-Small Cell Lung Cancer
Not applicableCompletedWashington University School of Medicine2172015-09-112021-04-08
Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers
Educational Intervention, Follow-Up Care, Psychosocial Assessment and Care - Cancer
Not applicableTerminatedVanderbilt-Ingram Cancer Center672015-05-012019-10-18
Cardiac Steatosis in Cushing's Syndrome
1H magnetic resonance spectroscopy and CMRI - Endocrine System Disease, Cardiovascular Imaging
Not applicableUnknownAssistance Publique - Hôpitaux de Paris602014-06-012016-09-29

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Neoplasms (3)  ·  Pain (2)  ·  Abdominal Pain (1)  ·  Anorexia (1)  ·  Breast Neoplasms (1)  ·  Bronchiectasis (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Burns (1)  ·  Carcinoma, Basal Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Carcinoma, Renal Cell (1)  ·  Cardiovascular Diseases (1)  ·  Cushing Syndrome (1)  ·  Disease (1)

Sponsors

SFJ Pharmaceuticals, Inc. (2)  ·  Vanderbilt-Ingram Cancer Center (2)  ·  Alberta Health Services, Calgary (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  City of Hope Medical Center (1)  ·  DiaSorin Inc. (1)  ·  Hacettepe University (1)  ·  Instituto de Investigacion Sanitaria La Fe (1)  ·  Italian Sarcoma Group (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)  ·  Madigan Army Medical Center (1)  ·  Nanjing First Hospital, Nanjing Medical University (1)  ·  Nantes University Hospital (1)  ·  Nationwide Children's Hospital (1)

Countries

United States (15)  ·  France (3)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Norway (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)

Top investigators

LuAnn Bundrant, MD (2)  ·  Adam Esbenshade, MD (1)  ·  Alfredo De Diego Damia, MD (1)  ·  Anita Gothelf, MD PhD (1)  ·  Brigitte Perrouin-Verbe, PU-PH (1)  ·  Celine Larkin, PhD (1)  ·  Claire Temple-Oberle, MD MSc FRCSC (1)  ·  Cliff Robinson, M.D. (1)  ·  Debra Friedman (1)  ·  Eric Jonasch (1)  ·  Erin O'Hea, PhD (1)  ·  Gulalai Hanan, MD (1)  ·  Gunnar Morken, PhD (1)  ·  Hala Borno, MD (1)  ·  Harald J. Hoekstra, MD, PhD (1)

Results publications

PMID 30883047, PMID 31565796, PMID 34151734, PMID 34333603, PMID 37043216, PMID 37874619, PMID 37972014, PMID 40442261, PMID 42238245, PMID 42453280

NIH funding

P30CA068485 (2), K12CA090625 (1), P30CA033572 (1), R34MH123578 (1)